Yükleniyor... / Loading...
This study aims to examine the features of the immune system (immune profiling) in people with multiple myeloma, a blood cancer. It enrolled newly diagnosed or treatment-refractory multiple myeloma patients as well as healthy volunteers. The study was a non-phased study and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * newly diagnosed MM patients or * refractory MM patients or * healthy donors. Esclusion criteria: * not newly diagnosed MM patients or * not refractory MM patients or * no healthy donors.